Back to today’s briefing

Story perspectives

Johnson & Johnson Reports $24.1B Sales, Eyes $100B Goal

4/14/2026

29 7 Full Breakdown

Summary

Story summary

Johnson & Johnson (J&J) reported first-quarter sales of $24.1 billion, up 9.9%.
Joaquin Duato, CEO of Johnson & Johnson (J&J), announced a 2026 revenue goal of $100 billion.
He raised full-year guidance to $100.8 billion.
The company faces talc lawsuits and Stelara exclusivity losses.
Icotyde, a newly approved psoriasis treatment, could become a major revenue source.

1 of 1

Story summary

Johnson & Johnson (J&J) reported first-quarter sales of $24.1 billion, up 9.9%.
Joaquin Duato, CEO of Johnson & Johnson (J&J), announced a 2026 revenue goal of $100 billion.
He raised full-year guidance to $100.8 billion.
The company faces talc lawsuits and Stelara exclusivity losses.
Icotyde, a newly approved psoriasis treatment, could become a major revenue source.